Telemedicine Company Equity Stake For Sale in Warsaw, Poland
Invest in a business with aims to tap the growing clinical trials market in Poland.
Premium Plan
| Established | 1-5 year(s) |
| Employees | 2 - 5 |
| Legal Entity | Private Limited Company |
| Reported Sales | Nil |
| Run Rate Sales | Nil |
| EBITDA Margin | Nil |
| Industries | Telemedicine |
| Locations | Warsaw |
| Local Time | 9:03 AM Europe / Warsaw |
| Listed By | Business Owner / Director |
| Status | Moderately Active |
Partial Stake Sale
USD
111 thousand
for
30.0%
stake
(Native Currency: PLN 400,000)
Reason: Insufficient own funds. We need more funds for faster development of the business.
Includes physical assets worth
USD
11 thousand
Interested to connect with advisors
Name, Phone, Email
Available after connect
Business Name
Available after connect
User Verification
Business Overview
- Upcoming medtech startup that will cater to the clinical trials market.
- Poland is emerging as a significant hub for clinical research in Europe, particularly for phase 3 trials across therapeutic areas like oncology, cardiology, dermatology, and neurology.
- Major cities like Warsaw and Krakow are key locations for conducting these trials due to their high patient recruitment rates and quality research facilities.
- Sponsors are attracted to Poland's harmonized regulatory environment, efficient research sites, and large patient pool, making it a compelling destination for global clinical trials.
- Our app will cater to the entire ecosystem of clinical trials and create a system wherein labs and sponsors can easily maintain records and communicate with patients.
- We have not finalized a revenue model but the labs, and sponsors will be our paying customers.
- We are in the incubation phase and our expected revenues within two years is approx. PLN 1-2 million.
- Owner's background: PM software development for international companies from the pharma, healthcare, news media, banking industries.
- Poland is emerging as a significant hub for clinical research in Europe, particularly for phase 3 trials across therapeutic areas like oncology, cardiology, dermatology, and neurology.
- Major cities like Warsaw and Krakow are key locations for conducting these trials due to their high patient recruitment rates and quality research facilities.
- Sponsors are attracted to Poland's harmonized regulatory environment, efficient research sites, and large patient pool, making it a compelling destination for global clinical trials.
- Our app will cater to the entire ecosystem of clinical trials and create a system wherein labs and sponsors can easily maintain records and communicate with patients.
- We have not finalized a revenue model but the labs, and sponsors will be our paying customers.
- We are in the incubation phase and our expected revenues within two years is approx. PLN 1-2 million.
- Owner's background: PM software development for international companies from the pharma, healthcare, news media, banking industries.
Products & Services Overview
Our medtech startup is developing an integrated digital platform that streamlines clinical trial operations for sponsors, research sites, and patients. While we are still in the incubation phase, our core offerings will cater to the entire clinical trial ecosystem.
Assets Overview
Tangible assets include our IT systems and other electronics.
Facilities Overview
We do not have properties and offices belonging to companies. We are currently working remotely.
Capitalization Overview
- The owner has invested PLN 400k of their own funds and they are able to finance all expenses related to IT systems.- There is one single owner.
Recent Activity
-
Earlier than 15 daysDirector, Pharmaceuticals - Chemicals Manufacturer, Mumbai, Individual Investor / Buyer connected with the Business
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business
1 Investor already contacted this Business.
Register below to connect now!
- Social
- Register
- Login
Who uses SMERGERS?
... and 64,000+ other businesses of all sizes.
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses